Detection of Ciprofloxacin-resistant, β-lactamase-producing Neisseria meningitidis Serogroup Y Isolates The Centers for Disease Control and Prevention (CDC) reports that 11 meningococcal disease cases reported in the United States during 2019–2020 had isolates containing a gene associated with penicillin resistance, as well as mutations associated with ciprofloxacin resistance. An additional 22 cases reported during 2013–2020 contained the penicillin resistance but did not have mutations associated with ciprofloxacin resistance.
Meningococcal disease, which typically presents as meningitis or meningococcemia, is a life-threatening illness caused by the bacterium Neisseria meningitidis and requiring prompt antibiotic treatment for patients and antibiotic prophylaxis for their close contacts. Neisseria meningitidis isolates in the United States have been largely susceptible to the antibiotics recommended for treatment and prophylaxis. For full information, click the links below:
4 Comments
|
AuthorThe Bureau of Health Care Quality and Compliance (HCQC) licenses medical and other health facilities, child care facilities and personnel, and medical laboratories and personnel in Nevada. HCQC also conducts compliance surveys and takes complaints. Archives
October 2023
Categories
All
|